• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过纳米结构脂质载体进行螺内酯的毛囊递送以治疗脱发

Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia.

作者信息

Shamma Rehab Nabil, Aburahma Mona Hassan

机构信息

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.

出版信息

Int J Nanomedicine. 2014 Nov 26;9:5449-60. doi: 10.2147/IJN.S73010. eCollection 2014.

DOI:10.2147/IJN.S73010
PMID:25473283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4251754/
Abstract

Spironolactone (SL) is a US Food and Drug Administration-approved drug for the treatment of hypertension and various edematous conditions. SL has gained a lot of attention for treating androgenic alopecia due to its potent antiandrogenic properties. Recently, there has been growing interest for follicular targeting of drug molecules for treatment of hair and scalp disorders using nanocolloidal lipid-based delivery systems to minimize unnecessary systemic side effects associated with oral drug administration. Accordingly, the objective of this study is to improve SL efficiency and safety in treating alopecia through the preparation of colloidal nanostructured lipid carriers (NLCs) for follicular drug delivery. SL-loaded NLCs were prepared by an emulsion solvent diffusion and evaporation method using 23 full factorial design. All of the prepared formulations were spherical in shape with nanometric size range (215.6-834.3 nm) and entrapment efficiency >74%. Differential scanning calorimetry thermograms and X-ray diffractograms revealed that SL exists in amorphous form within the NLC matrices. The drug release behavior from the NLCs displayed an initial burst release phase followed by sustained release of SL. Confocal laser scanning microscopy confirmed the potential of delivering the fluorolabeled NLCs within the follicles, suggesting the possibility of using SL-loaded NLCs for localized delivery of SL into the scalp hair follicles.

摘要

螺内酯(SL)是一种经美国食品药品监督管理局批准用于治疗高血压和各种水肿病症的药物。由于其强大的抗雄激素特性,SL在治疗雄激素性脱发方面备受关注。最近,人们越来越有兴趣利用基于纳米胶体脂质的递送系统将药物分子靶向毛囊,以治疗毛发和头皮疾病,从而尽量减少与口服给药相关的不必要的全身副作用。因此,本研究的目的是通过制备用于毛囊药物递送的胶体纳米结构脂质载体(NLCs)来提高SL治疗脱发的效率和安全性。采用23全因子设计,通过乳液溶剂扩散和蒸发法制备了载有SL的NLCs。所有制备的制剂均呈球形,粒径在纳米范围内(215.6 - 834.3 nm),包封率>74%。差示扫描量热法热谱图和X射线衍射图显示,SL以无定形形式存在于NLC基质中。NLCs的药物释放行为表现为初始突释阶段,随后是SL的持续释放。共聚焦激光扫描显微镜证实了将荧光标记的NLCs递送至毛囊内的可能性,这表明使用载有SL的NLCs将SL局部递送至头皮毛囊的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/99948970dcde/ijn-9-5449Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/6c3132e5e8cd/ijn-9-5449Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/5d4b1c4f444c/ijn-9-5449Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/9a5855e139d4/ijn-9-5449Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/fa86480ae942/ijn-9-5449Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/cd7dca923c19/ijn-9-5449Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/e00d31cd97c8/ijn-9-5449Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/0a408e91fa30/ijn-9-5449Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/0d140fbaa3d9/ijn-9-5449Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/99948970dcde/ijn-9-5449Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/6c3132e5e8cd/ijn-9-5449Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/5d4b1c4f444c/ijn-9-5449Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/9a5855e139d4/ijn-9-5449Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/fa86480ae942/ijn-9-5449Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/cd7dca923c19/ijn-9-5449Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/e00d31cd97c8/ijn-9-5449Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/0a408e91fa30/ijn-9-5449Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/0d140fbaa3d9/ijn-9-5449Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8036/4251754/99948970dcde/ijn-9-5449Fig9.jpg

相似文献

1
Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia.通过纳米结构脂质载体进行螺内酯的毛囊递送以治疗脱发
Int J Nanomedicine. 2014 Nov 26;9:5449-60. doi: 10.2147/IJN.S73010. eCollection 2014.
2
Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.负载度他雄胺的硬脂酸 - 壳聚糖低聚物包衣纳米结构脂质载体的制备及其表征,用于局部给药。
Eur J Pharm Biopharm. 2017 Aug;117:372-384. doi: 10.1016/j.ejpb.2017.04.012. Epub 2017 Apr 12.
3
Histological evaluation of follicular delivery of arginine via nanostructured lipid carriers: a novel potential approach for the treatment of alopecia.通过纳米结构脂质载体进行毛囊内精氨酸传递的组织学评价:治疗脱发的一种新的潜在方法。
Artif Cells Nanomed Biotechnol. 2017 Nov;45(7):1379-1387. doi: 10.1080/21691401.2016.1241794. Epub 2016 Oct 31.
4
Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia.固体脂质纳米粒介导氟他胺毛囊递送的组织学评估:治疗雄激素性脱发的潜在工具
Drug Dev Ind Pharm. 2016;42(6):846-53. doi: 10.3109/03639045.2015.1062896. Epub 2015 Jul 7.
5
Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).基于质量源于设计(QbD)理念开发的醋氯芬酸纳米结构脂质载体(NLCs):改善炎症性疾病的皮肤动力学特征。
Int J Pharm. 2017 Jan 30;517(1-2):413-431. doi: 10.1016/j.ijpharm.2016.12.010. Epub 2016 Dec 9.
6
Cyproterone acetate-loaded nanostructured lipid carriers: effect of particle size on skin penetration and follicular targeting.载有醋酸环丙孕酮的纳米结构脂质载体:粒径对皮肤渗透和毛囊靶向的影响。
Pharm Dev Technol. 2019 Sep;24(7):812-823. doi: 10.1080/10837450.2019.1596133. Epub 2019 Apr 26.
7
Squalene-containing nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of diphencyprone for treating alopecia areata.含角鲨烯的纳米结构脂质载体促进二苯环丙烯酮经皮吸收和靶向毛囊治疗斑秃。
Pharm Res. 2013 Feb;30(2):435-46. doi: 10.1007/s11095-012-0888-0. Epub 2012 Oct 16.
8
Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery.载多西紫杉醇-烟酰胺复合物的纳米结构脂质载体经皮给药。
Int J Pharm. 2013 Dec 31;458(2):296-304. doi: 10.1016/j.ijpharm.2013.10.036. Epub 2013 Oct 28.
9
Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.用于银屑病局部治疗的载有丙酮缩氟氢羟龙的纳米结构脂质载体的设计、表征及皮肤渗透潜力
Steroids. 2015 Sep;101:56-63. doi: 10.1016/j.steroids.2015.05.012. Epub 2015 Jun 3.
10
Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.米诺地尔纳米结构脂质载体的制备与表征
AAPS PharmSciTech. 2017 Feb;18(2):509-516. doi: 10.1208/s12249-016-0519-x. Epub 2016 Apr 27.

引用本文的文献

1
Advances in Transdermal Delivery Systems for Treating Androgenetic Alopecia.治疗雄激素性脱发的透皮给药系统进展
Pharmaceutics. 2025 Jul 30;17(8):984. doi: 10.3390/pharmaceutics17080984.
2
Targeting Acne: Development of Monensin-Loaded Nanostructured Lipid Carriers.靶向治疗痤疮:载莫能菌素纳米结构脂质载体的研发
Int J Nanomedicine. 2025 Feb 19;20:2181-2204. doi: 10.2147/IJN.S497108. eCollection 2025.
3
A Systematic Review of Spironolactone Nano-Formulations for Topical Treatment of Skin Hyperandrogenic Disorders and Chronic Wounds.

本文引用的文献

1
Preparation, characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial design.采用统计析因设计制备、表征并优化载有枸橼酸西地那非的 PLGA 纳米粒。
Daru. 2013 Dec 19;21(1):68. doi: 10.1186/2008-2231-21-68.
2
Female pattern alopecia: current perspectives.女性型脱发:当前观点
Int J Womens Health. 2013 Aug 29;5:541-56. doi: 10.2147/IJWH.S49337.
3
Transdermal delivery of betahistine hydrochloride using microemulsions: physical characterization, biophysical assessment, confocal imaging and permeation studies.
螺内酯纳米制剂用于局部治疗皮肤高雄激素性疾病和慢性伤口的系统评价
Pharmaceutics. 2024 Dec 27;17(1):27. doi: 10.3390/pharmaceutics17010027.
4
Green Formulation of Spironolactone Loaded Chitosan-Coated Nano Lipid Carrier for Treatment of Acne Vulgaris: A Randomized Double-Blind Clinical Trial.载有螺内酯的壳聚糖包衣纳米脂质载体绿色制剂治疗寻常痤疮:一项随机双盲临床试验
Adv Pharm Bull. 2024 Mar;14(1):161-175. doi: 10.34172/apb.2024.011. Epub 2023 Sep 23.
5
An Overview of Nanostructured Lipid Carriers and its Application in Drug Delivery through Different Routes.纳米结构脂质载体概述及其在不同给药途径中的药物递送应用。
Adv Pharm Bull. 2023 Jul;13(3):446-460. doi: 10.34172/apb.2023.056. Epub 2022 Sep 18.
6
Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine: Statistical Optimization and Pharmacological Evaluations.纳米结构脂质载体提高雷诺嗪的生物利用度和溶解度:统计优化与药理学评价
Pharmaceuticals (Basel). 2023 Aug 14;16(8):1151. doi: 10.3390/ph16081151.
7
Augmented Transdermal Delivery of Curcumin for the Effective Management of Plaque Psoriasis - Design, Formulation, Characterisation, and In Vivo Studies.姜黄素经皮给药增强传递用于斑块状银屑病的有效治疗:设计、配方、特性描述和体内研究。
AAPS PharmSciTech. 2023 Jun 8;24(5):134. doi: 10.1208/s12249-023-02595-8.
8
The Idiosyncratic Efficacy of Spironolactone-Loaded PLGA Nanoparticles Against Murine Intestinal Schistosomiasis.螺内酯载 PLGA 纳米粒治疗小鼠肠道血吸虫病的独特疗效。
Int J Nanomedicine. 2023 Feb 22;18:987-1005. doi: 10.2147/IJN.S389449. eCollection 2023.
9
Repurposing of atorvastatin emulsomes as a topical antifungal agent.将阿托伐他汀乳剂重新用于局部抗真菌剂。
Drug Deliv. 2022 Dec;29(1):3414-3431. doi: 10.1080/10717544.2022.2149898.
10
Microneedle mediated transdermal delivery of β-sitosterol loaded nanostructured lipid nanoparticles for androgenic alopecia.微针介导的载 β-谷甾醇纳米结构脂质载体经皮给药治疗雄激素性脱发。
Drug Deliv. 2022 Dec;29(1):3022-3034. doi: 10.1080/10717544.2022.2120927.
盐酸倍他司汀经皮给药微乳的物理特性表征、生物物理评估、共聚焦成像和渗透研究。
Colloids Surf B Biointerfaces. 2013 Oct 1;110:254-60. doi: 10.1016/j.colsurfb.2013.05.007. Epub 2013 May 13.
4
Topical delivery of enoxaparin using nanostructured lipid carrier.采用纳米结构脂质载体递送达肝素。
J Microencapsul. 2013;30(7):709-15. doi: 10.3109/02652048.2013.778908. Epub 2013 Mar 27.
5
Visualization of ultradeformable liposomes penetration pathways and their skin interaction by confocal laser scanning microscopy.利用共聚焦激光扫描显微镜观察超弹性脂质体的渗透途径及其与皮肤的相互作用。
Int J Pharm. 2013 Jan 30;441(1-2):151-61. doi: 10.1016/j.ijpharm.2012.12.003. Epub 2012 Dec 13.
6
Preparation and evaluation of montelukast sodium loaded solid lipid nanoparticles.孟鲁司特钠固体脂质纳米粒的制备与评价
J Young Pharm. 2012 Jul;4(3):129-37. doi: 10.4103/0975-1483.100016.
7
Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles.载有枸橼酸西地那非的纳米结构脂质载体与固体脂质纳米粒的制备、评价及经皮渗透。
Int J Nanomedicine. 2011;6:3195-205. doi: 10.2147/IJN.S25825. Epub 2011 Dec 6.
8
Improved and safe transcorneal delivery of flurbiprofen by NLC and NLC-based hydrogels.通过 NLC 和基于 NLC 的水凝胶提高和增强氟比洛芬的经角膜传递安全性。
J Pharm Sci. 2012 Feb;101(2):707-25. doi: 10.1002/jps.22784. Epub 2011 Oct 19.
9
Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.载药固体脂质纳米粒的处方前设计、制备及理化性质考察:工艺变量的影响。
Colloids Surf B Biointerfaces. 2011 Nov 1;88(1):483-9. doi: 10.1016/j.colsurfb.2011.07.036. Epub 2011 Jul 23.
10
Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.应用药物质量源于设计(QbD)提高聚合物表面活性剂和结晶抑制剂对 II 类 BCS 药物的溶解度和溶出度:控释片剂的开发。
AAPS PharmSciTech. 2011 Sep;12(3):799-810. doi: 10.1208/s12249-011-9646-6. Epub 2011 Jun 24.